Glenmark Pharma and SaNOtize announce results of its phase-III clinical trials on SaNOtize’s Nitric Oxide nasal spray Read more
Roche’s Faricimab improves and maintains vision in two leading causes of vision loss: Lancet Read more
Covaxin shows 50 per cent effectiveness against symptomatic COVID in real-world assessment: Lancet study Read more